Back
Avenue Therapeutics Quote, Financials, Valuation and Earnings
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
ATXI
Avenue Therapeutics
Last Price:
2.61
Seasonality Move:
-29.84%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketAvenue Therapeutics Price Quote
$2.61
Avenue Therapeutics Key Stats
Sell
14
Avenue Therapeutics (ATXI)
is a Sell
Day range:
$2.60 - $2.75
52-week range:
$2.25 - $54.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.78%
Volume:
10.5K
Avg. volume:
24.9K
1-year change:
-95.54%
Market cap:
$3.7M
Revenue:
$0
EPS:
$-15.45
How Much Does Avenue Therapeutics Make?
Data Unavailable
Is Avenue Therapeutics Growing As A Company?
Data Unavailable
Avenue Therapeutics Stock Price Performance
-
Did Avenue Therapeutics Stock Go Up Last Month?
Avenue Therapeutics share price went down by -10.62% last month -
Did ATXI's Share Price Rise Over The Last Year?
ATXI share price fell by -95.54% over the past 1 year
What Is Avenue Therapeutics 52-Week High & Low?
-
What Is Avenue Therapeutics’s 52-Week High Share Price?
Avenue Therapeutics has traded as high as $54.74 over the past 52 weeks -
What Is Avenue Therapeutics’s 52-Week Low Share Price?
Avenue Therapeutics has traded as low as $2.25 over the past 52 weeks
Avenue Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avenue Therapeutics?
-
How Much Debt Does Avenue Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avenue Therapeutics Have?
Cash and short term investments quarterly total is $4.9M -
What Is Avenue Therapeutics’s Book Value Per Share?
Book value per share is 4.00
Is Avenue Therapeutics Cash Flow Positive?
-
What Is ATXI Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.6M -
What Is Avenue Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.9M -
What Is Avenue Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Avenue Therapeutics Return On Invested Capital
Data Unavailable
Avenue Therapeutics Earnings Date & Stock Price
-
What Is Avenue Therapeutics's Stock Price Today?
A single share of ATXI can be purchased today for 2.61 -
What Is Avenue Therapeutics’s Stock Symbol?
Avenue Therapeutics trades on the nasdaq under the ticker symbol: ATXI -
When Is Avenue Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Avenue Therapeutics is scheduled on November 13, 2024 -
When Is ATXI's next ex-dividend date?
Avenue Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Avenue Therapeutics Stock?
You can buy Avenue Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avenue Therapeutics Competitors
-
Who Are Avenue Therapeutics's Competitors?
Below is a list of companies who compete with Avenue Therapeutics or are related in some way:
Avenue Therapeutics Dividend Yield
-
What Is ATXI Dividend Yield?
Avenue Therapeutics’s dividend yield currently is 0% -
What Is Avenue Therapeutics’s Payout Ratio?
Avenue Therapeutics’s payout ratio is 0% -
When Did Avenue Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Avenue Therapeutics’s Dividend Per Share?
Avenue Therapeutics pays a dividend of $0.00 per share
Avenue Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 12.00 |
| Upside from Last Price: | 359.77% |